Axcelis Technologies (NASDAQ:ACLS) Issues Earnings Results
by Teresa Graham · The Cerbat GemAxcelis Technologies (NASDAQ:ACLS – Get Free Report) posted its earnings results on Thursday. The semiconductor company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.15, FiscalAI reports. The company had revenue of $237.78 million for the quarter, compared to the consensus estimate of $230.08 million. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%. The company’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.21 earnings per share. Axcelis Technologies updated its Q4 2026 guidance to 1.500-1.500 EPS.
Here are the key takeaways from Axcelis Technologies’ conference call:
- Axcelis reported Q3 revenue of $238 million and diluted EPS of $1.26, both ahead of its expectations. CS&I revenue reached a quarterly record of $93 million.
- Gross margin was 41.2%, below the 43% outlook, mainly because the stronger Korean won increased costs; foreign-exchange gains in other income partly offset the impact.
- Bookings rose to $222 million, the highest since Q4 2023, with a 1.5 book-to-bill ratio and backlog reaching $531 million. Management described demand as broadening across power, memory and general mature markets, and expects all three to grow in 2027.
- For Q4, Axcelis forecast revenue of about $275 million and EPS of about $1.50, with growth primarily from power and general mature. It expects Q1 2027 revenue to be relatively consistent with Q4 despite seasonal CS&I softness.
- The pending Veeco merger is now expected to close by the end of Q1 2027, subject to regulatory clearance in China and a new HSR submission.
Axcelis Technologies Stock Down 2.3%
NASDAQ ACLS traded down $2.14 during trading hours on Thursday, hitting $90.00. 1,036,275 shares of the company were exchanged, compared to its average volume of 328,929. The company has a quick ratio of 3.21, a current ratio of 4.90 and a debt-to-equity ratio of 0.04. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of 23.57, a PEG ratio of 2.81 and a beta of 1.88. The company has a 50 day moving average of $116.08 and a two-hundred day moving average of $122.65. Axcelis Technologies has a 52-week low of $73.60 and a 52-week high of $193.78.
Key Stories Impacting Axcelis Technologies
Here are the key news stories impacting Axcelis Technologies this week:
- Positive Sentiment: Q3 adjusted EPS was $1.26, ahead of the $1.11 consensus estimate, while revenue of $237.8 million topped the $230.1 million estimate and rose 11.3% year over year. Zacks article
- Positive Sentiment: Q4 guidance was well above analyst expectations: Axcelis forecast EPS of $1.50 versus $1.18 consensus and revenue of $275 million versus $239.3 million. The outlook suggests stronger near-term results than investors had anticipated. Axcelis Q3 results release
- Neutral Sentiment: The earnings-call transcript was published, but the provided article details do not identify additional developments beyond the reported results and guidance. Earnings call transcript
- Neutral Sentiment: Although ACLS shares moved lower, the supplied news points to stronger-than-expected earnings and guidance and provides no clear negative company-specific catalyst to explain the decline.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on the company. Craig Hallum cut Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 target price for the company. in a report on Friday, August 7th. Weiss Ratings raised shares of Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 16th. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Axcelis Technologies presently has a consensus rating of “Hold” and an average target price of $148.67.
View Our Latest Analysis on Axcelis Technologies
About Axcelis Technologies
Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.
Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.
Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.
Read More
- Five stocks we like better than Axcelis Technologies
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market